LabCompass

Emma M. Tillman

Medicine · Indiana University

OpenAlex ORCID
Cystic Fibrosis Research AdvancesPharmaceutical studies and practicesClinical Nutrition and GastroenterologyPharmacogenetics and Drug MetabolismChildhood Cancer Survivors' Quality of Life

Publications

100

Citations

802

Est. group size

—

Recurring co-author estimate

Active years

44

Publishing since 1983

Research summary
AI-generated

Emma M. Tillman studies how genetic differences affect the way patients respond to medications (pharmacogenomics), with a strong focus on cystic fibrosis, a genetic disease affecting the lungs and digestive system. Much of the recent work examines newer cystic fibrosis drugs called CFTR modulators, including their effects on mental health, as well as broader questions of medication safety and personalized (precision) medicine. Additional research touches on drug toxicity, transplant donor outcomes, and pediatric care.

Cystic fibrosis and CFTR modulator therapiesPharmacogenomics and personalized medicineMedication safety and drug toxicityMental health effects of medicationsPediatric pharmacology

Publication activity has grown over the last decade, rising from a few papers per year in the late 2010s to roughly 9-15 per year recently.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 9.4/year recently
2017: 1 publication172018: 2 publications182019: 3 publications192020: 9 publications202021: 12 publications212022: 7 publications222023: 10 publications232024: 15 publications15242025: 11 publications252026: 4 publications26
Recent publications
Publishes in
  • Journal of Cystic Fibrosis×11
  • Pediatric Pulmonology×7
  • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy×6
  • The Journal of Pediatric Pharmacology and Therapeutics×6
  • Clinical and Translational Science×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile